Laboratorios Leon Farma S.A. (production of intermediate products (dutasteride soft gelatin capsules), and finished medicinal product; primary and secondary packaging, quality control (chemical/physical))

The drug is intended for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and decreases the likelihood of the need for surgical intervention.

Dosage form: capsules, hard

ATC: G04CA52